<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>46</Volume>
      <Issue>8</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Survival Rates among Co-infected Patients with Human  Immunodeficiency Virus/Tuberculosis in Tehran, Iran</title>
    <FirstPage>1123</FirstPage>
    <LastPage>1131</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Ghodratollah</FirstName>
        <LastName>ROSHANAEI</LastName>
        <affiliation locale="en_US">Modeling of Noncommunicable Diseases Research Center, Dept. of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>SABOURI GHANNAD</LastName>
        <affiliation locale="en_US">Research Center for Molecular Medicine, Dept. of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Jalal</FirstName>
        <LastName>POOROLAJAL</LastName>
        <affiliation locale="en_US">Research Center for Health Sciences, Dept. of Epidemiology &amp; Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Minoo</FirstName>
        <LastName>MOHRAZ</LastName>
        <affiliation locale="en_US">Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Leila</FirstName>
        <LastName>MOLAEIPOOR</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology and Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>07</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The number of deaths related with co-infection of tuberculosis (TB) and HIV remains inappropriately high worldwide. TB is anticipated to be the major reason of HIV-related deaths globally. This study aimed to find out and evaluate the characteristics of the possible risk factors influencing the survival time of co-infected patients with HIV/TB in Tehran the capital of Iran.
&#xD;

Methods: This retrospective study was performed on the referred patients to the one of two Behavioral Diseases Coun&#xAD;seling Centers, Imam Khomeini, and Zamzam Centers, Tehran, Iran, in 2004-2013. Data were analyzed by Cox PH model utilizing SPSS16 statistical software.
&#xD;

Results: Multivariate analysis confirmed that the age at diagnosis (P=0.014), gender (P=0.002), sexual transmission (P=0.01), cotrimoxazole preventive therapy (P&lt;0.001), and onset to TB after post-HIV diagnosis (P=0.01) were the parameters which had significant effects on the death of HIV/TBco-infected patients.
&#xD;

Conclusion: The results, recommend interplay between different risk factors and the risk of death in co-infected patients with HIV/TB. We presented the barriers to higher-level organizational and functional integration for commitment to interfere with the modifiable risk factors, which effect on the mortality of patients.
&#xD;

&#xA0;</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/10614</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/10614/5260</pdf_url>
  </Article>
</Articles>
